Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-cjp7w Total loading time: 0 Render date: 2024-06-30T02:14:21.349Z Has data issue: false hasContentIssue false

13 - Adherence to antiretroviral therapy in children and youth

from Part II - General issues in the care of pediatric HIV patients

Published online by Cambridge University Press:  03 February 2010

John Farley
Affiliation:
Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD
Steven L. Zeichner
Affiliation:
National Cancer Institute, Bethesda, Maryland
Jennifer S. Read
Affiliation:
National Cancer Institute, Bethesda, Maryland
Get access

Summary

Improved health outcomes for HIV-infected children and youth will not be achieved without maximal viral suppression. Highly active antiretroviral therapy (HAART) represents a major breakthrough in HIV management, but not all patients respond optimally to HAART. Non-adherence is well established as a major cause of clinical failure, and intermittent non-adherence is a particular problem. Studies in adults have demonstrated that ≥ 95% adherence to HAART is necessary for durable suppression of viral load [1–3]. In the presence of selective pressure by antiretroviral agents, high rates of viral replication and viral mutation lead to the development of drug resistance. Mutations conferring resistance against one antiretroviral agent often confer cross-resistance to other agents; poor adherence can render a whole class of antiretrovirals ineffective.

Although a crucial component of good clinical care, assessment of adherence to HAART in HIV-infected children and youth is challenging and labor intensive. Patient and parent (or other caregiver) characteristics associated with optimal adherence are not well characterized. Studies evaluating interventions to improve adherence in this group are encouraging but few.

HIV as a chronic illness

Pediatric HIV infection is now referred to as the ‘newest chronic illness in childhood’ [4, 5]. Chronic illness alters a person's life by creating permanent changes in daily living. The person must adhere to a medical regimen even though there is no cure, often in the absence of visible symptoms. While our understanding of HIV therapy is evolving, life-long treatment will likely be required.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Miller, L. D. & Hays, R. D.Adherence to combination antiretroviral therapy: synthesis of the literature and clinical implications. Acquired Immune Deficiency Syndrome Reader 10 (2000), 177–85Google ScholarPubMed
Gifford, A. L., Bormann, J. E., Shively, M. J., Wright, B. C., Richman, D. D. & Bozzette, S. A.Predictors of self-reported adherence and plasma Human Immunodeficiency Virus concentrations in patients on multi-drug antiretroviral regimens. J. Acquired Immune Deficiency Syndrome 23 (2000), 386–95CrossRefGoogle Scholar
Arnsten, J. H., Demas, P. A., Farzadegan, H.. Antiretroviral therapy adherence and viral suppression in Human Immunodeficiency Virus-infected drug users: comparison of self-report and electronic monitoring. Clin. Infect. Dis. 33 (2001), 1417–23CrossRefGoogle Scholar
Lipson, M.What do you say to a child with Acquired Immune Deficiency Syndrome?Hastings Cent. Rep. 23 (1993), 6–12CrossRefGoogle Scholar
Maieron, M. J., Roberts, M. C. & Prentice-Dunn, S.Children's perception of peers with Acquired Immune Deficiency Syndrome. Assessing the impact of contagion information, perceived similarity, and illness conceptualization. J. of Pediatr. Psychol. 21 (1996), 321–34CrossRefGoogle ScholarPubMed
Cameron, K. & Gregor, F.. Chronic illness and compliance. J. Advanced Nurs. 12 (1987), 671–6CrossRefGoogle ScholarPubMed
Parrish, J. Parent compliance with medical and behavioral recommendations. In N. Krasnegor, J. Arasteh & M. Cataldo (eds.), Child Health Behavior. New York, NY: John Wiley & Sons (1986), pp. 453–501
Thompson, R. J. & Gustafson, K. E. Adaption to chronic childhood illness. Washington, Dendritic Cells: American Psychological Association (1996)
LaGreca, A. & Schuman, W. B. Adherence to prescribed medical regimens. In M. C. Roberts (ed.), Handbook of Pediatric Psychology. 2nd edn. New York, NY: Guilford Press (1995), pp. 55–83
Peterson, L.. Coping by children undergoing stressful medical procedures: some conceptual, methodological, and therapeutic issues. J. Consult. Clin. Psychol. 57 (1989), 380–7CrossRefGoogle ScholarPubMed
Becker, M. H., Maiman, L. A., Kirscht, J. P. et al. Patient perceptions and compliance: recent studies of the health belief model. In R. B. Haynes, D. W. Taylor & D. L. Sackett (eds.), Compliance in Health Care. Baltimore, MD: Johns Hopkins University Press (1979)
Rosenstock, I. M., Strecher, V. J. & Becker, M. H.Social learning theory and the Health Belief Model. Health Educ. Quart. 15 (1988), 175–83CrossRefGoogle ScholarPubMed
Besch, C. L., Morse, E., Simon, P. et al. Preliminary results of a compliance study within CPCRA 007 Combination Nucleoside Study. In Fourth Conference on Retroviruses and Opportunistic Infections Washington, Dendritic Cells: 1997
Laine, C., Newschaffer, C. J., Zhang, D., Cosler, L., Hauck, W. W. & Turner, B. J.Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: a pharmacy claims-based analysis. Obstet. Gynecol. 95 (2000), 167–73Google ScholarPubMed
Gordillo, V., del Amo, J., Soriano, V. & Gonzalez-Lahoz, J.Sociodemographic and psychologic variables influencing adherence to antiretroviral therapy. Acquired Immune Deficiency Syndrome 13 (1999), 1763–9Google Scholar
Prochaska, J. O. &? Systems of psychotherapy: A transtheoretical analysis. Homewood Interleukin: Dorsey Press (1979)
Prochaska, J. O. & DiClemente, C. C.Stages and processes of self-change of smoking: toward an integrative model of change. J. Consult. Clinic. Psychol. 51 (1983), 390–5CrossRefGoogle Scholar
Prochaska, J. O., DiClemente, C. C. & Norcross, J. C.In search of how people change: applications to addictive behaviors. Am. Psychol. 47 (1992), 1102–14CrossRefGoogle ScholarPubMed
DiClemente, C. C. Motivational interviewing and the stage of change. In W. R. Miller & S. Rollnick (eds.), Motivational Interviewing: Preparing People for Change. New York, NY: Guilford Press (1991)
Rogers, A. S., Miller, S., Murphy, D. A., Tanney, M. & Fortune, T.The Treatment Regimens Enhancing Adherence in Teens (therapeutic regimens enhancing adherence in teens) program: theory and preliminary results. J. Adoles. Health 292S (1991), 30–8Google Scholar
Gordis, L., Markowitz, M. & Lilienfield, A. M.The inaccuracy in using interview to estimate patient reliability in taking medications at home. Med. Care 17 (1969), 49–54CrossRefGoogle Scholar
Haynes, R. B., Taylor, D. W., Sackett, D. L., Gibson, E. S., Bernholz, C. D. & Mukherjee, J.Can simple clinical measurements detect patient noncompliance?Hypertension 2 (1980), 757–64CrossRefGoogle ScholarPubMed
Dyke, R. B., Lee, S., Johnson, G. M.. Reported adherence as a determinant of response to highly active antiretroviral therapy in Human Immunodeficiency Virus-infected children. Pediatrics 109 (2002), e61CrossRefGoogle Scholar
Reddington, C., Cohen, J., Raldillo, A.. Adherence to medication regimens among children with human immunodeficiency virus infection. Pediatr. Infect. Dis.J. 19 (2000), 1148–53CrossRefGoogle ScholarPubMed
Steele, R. G., Anderson, B., Rindel, B.. Adherence to antiretroviral therapy among Human Immunodeficiency Virus-positive children: examination of the role of caregiver health beliefs. Acquired Immune Deficiency Syndrome Care 13 (2001), 617–29Google Scholar
Farley, J. J., Hines, S. E., Musk, A. E., Ferrus, S. & Tepper, V. E.Assessment of adherence to antiviral therapy in Human Immunodeficiency Virus-infected children using the medication event monitoring system (Medication Event Monitoring System) compared with pharmacy refill, provider assessment, and caregiver self-report. J. Acquired Immune Deficiency Syndrome 33 (2003), 211–18CrossRefGoogle Scholar
Parienti, J. J., Verdon, R., Bazin, C., Bouvet, E., Massari, V. & Larouze, B.The pills identification test: a tool to assess adherence to antiretroviral therapy. J. Am. Med. Assoc. 285 (2001), 412CrossRefGoogle ScholarPubMed
Metzger, D. S., Koblin, B., Turner, C.. Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team. Am. J. Epidemiol. 152 (2000), 99–106CrossRefGoogle ScholarPubMed
Caron, H. S. & Roth, H. P.Patient's cooperation with a medical regimen. J. Am. Med. Assoc. 203 (1968), 922–6CrossRefGoogle Scholar
Davis, M. S.Variations in patients' compliance with doctors' orders: analysis of congruence between survey responses and results of empirical investigations. J. Med. Educ. 41 (1966), 1037–48Google ScholarPubMed
Mushlin, A. I. & Appel, F. A.Diagnosing potential noncompliance: physician's ability in a behavioral dimension of medical care. Arch. Intern. Med. 137 (1977), 318–21CrossRefGoogle Scholar
Bangsberg, D. R., Hecht, F. M., Clague, H.. Provider assessment of adherence to Human Immunodeficiency Virus antiretroviral therapy. J. Acquired Immune Deficiency Syndrome 26 (2001), 435–42CrossRefGoogle Scholar
Charney, E., Bynum, R., Eldredge, D.. How well do patients take oral penicillin? A collaborative study in private practice. Pediatrics 40 (1967), 188–95Google ScholarPubMed
Wood, H. F., Feinstein, A. R., Taranta, A.. Rheumatic fever in children and adolescents: a long-term epidemiologic study of subsequent prophylaxis, streptococcal infections, and clinical sequelae. Ann. Intern. Med. 60 (suppl.) (1964), 31–46CrossRefGoogle ScholarPubMed
Maher, K., Klimas, N., Fletcher, M. A.. Disease progression, adherence, and response to protease inhibitor therapy for Human Immunodeficiency Virus infection in an urban Veteran's Affairs medical center. J. Acquired Immune Deficiency Syndrome 22 (1999), 358–63CrossRefGoogle Scholar
Turner, B. J., Newschaffer, C. J., Zhang, D., Cosler, L. & Houch, W. W.Antiretroviral use and pharmacy-based measurement of adherence in post-partum Human Immunodeficiency Virus-infected women. Med. Care 38 (2000), 911–25CrossRefGoogle Scholar
Low-Beer, S., Yip, B., O'Shaughnessy, M. V., Hogg, R. S. & Montaner, J. S. G.Adherence to triple therapy and viral load response. J. Acquired Immune Deficiency Syndrome 23 (2000), 360–1CrossRefGoogle ScholarPubMed
Watson, D. C. & Farley, J. J.Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1. Pediatr. Infect. Dis. J. 18 (1999), 682–9CrossRefGoogle ScholarPubMed
Vanhove, G. F., Schapiro, J. M., Winters, M. A.. Patient compliance and drug failure in protease inhibitor monotherapy. J. Am. Med. Assoc. 276 (1996), 1955–6CrossRefGoogle ScholarPubMed
Liu, H., Golin, C. E., Miller, L. G.. A comparison study of multiple measures of adherence to Human Immunodeficiency Virus protease inhibitors. Ann. Intern. Med. 134 (2001), 968–77CrossRefGoogle Scholar
Bangsberg, D. R., Hecht, F. M., Charlebois, E. D.. Adherence to protease inhibitors, Human Immunodeficiency Virus-1 viral load, and development of drug resistance in an indigent population. Acquired Immune Deficiency Syndrome 14 (2000), 357–66Google Scholar
Paterson, D. L., Swindells, S., Mohr, J.. Adherence to protease inhibitor therapy and outcomes in patients with Human Immunodeficiency Virus infection. Ann. Intern. Med. 133 (2000), 21–30CrossRefGoogle Scholar
Tuldra, A., Ferrer, M. J. & Fumaz, C. R.Monitoring adherence to Human Immunodeficiency Virus therapy [letter]. Arch. Intern. Med. 159 (1999), 1376–7CrossRefGoogle Scholar
Samet, J. H., Libman, H. & Steger, K. A.Compliance with zidovudine in patients infected with human immunodeficiency virus, type 1: a cross-sectional study in a municipal hospital clinic. Am. J. Med. 92 (1992), 495–502CrossRefGoogle Scholar
Murri, R., Ammassari, A., Gallicano, K.. Patient reported nonadherence to Highly Active Antiretroviral Therapy is related to protease inhibitor levels. J. Acquired Immune Deficiency Syndrome 24 (2000), 123–8CrossRefGoogle Scholar
Albano, F., Spagnuolo, M. I., Berni Canani, R. & Guarino, A.Adherence to antiretroviral therapy in Human Immunodeficiency Virus-infected children in Italy. Acquired Immune Deficiency Syndrome Care 11 (1999), 711–14Google Scholar
Kastrissios, H., Suarez, J. R., Hammer, S.. The extent of non-adherence in a large Acquired Immune Deficiency Syndrome clinical trial using plasma dideoxynucleoside concentrations as a marker. Acquired Immune Deficiency Syndrome 12 (1998), 2305–11Google Scholar
Eldred, L. J., Wu, A. W., Chaisson, R. E. & Moore, R. D.Adherence to antiretroviral and pneumocystis prophylaxis in Human Immunodeficiency Virus disease. J. Acquired Immune Deficiency Syndrome 18 (1998), 117–25CrossRefGoogle Scholar
Dahlquist, L. M. & Blount, R. L.Teach a six-year-old girl toswallow pills. J. Behav. Ther. Exper. Psychiatry 15 (1984), 171–3CrossRefGoogle ScholarPubMed
Shingadia, D., Viani, R. M., Yogev, R.. Gastrostomy tube insertion for improvement of adherence to highly active antiretroviral therapy in pediatric patients with human immunodeficiency virus. Pediatrics 105 (2000), e80CrossRefGoogle ScholarPubMed
Chesney, M. A.Factors affecting adherence to antiretroviral therapy. Clin. Infect. Dis. 30 (Suppl. 2) (2000), S171–6CrossRefGoogle ScholarPubMed
Carney, R. M., Schechter, K. & Davis, T.Improving adherence to blood glucose testing in insulin-dependent diabetic children. Behav. Ther. 14 (1983), 247–54CrossRefGoogle Scholar
Reynolds, E., Berrien, V., Acosta-Glynn, C. & Salazar, J. Home based, intense, nursing intervention trial improves adherence to Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus infected children. In Pediatric Academic Societies 2001 Annual Meeting. Baltimore, MD (2001)
Altice, F. L.Trust and the acceptance of and adherence to antiretroviral therapy. J. Acquired Immune Deficiency Syndrome 28 (2001), 47–58CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×